Alessandro Larcher

IRCCS Ospedale San Raffaele — Italy

Medicine · Health Sciences

48h-index8.4kcitations687works1.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Renal cell carcinoma treatment(390), Bladder and Urothelial Cancer Treatments(160), Renal and Vascular Pathologies(129), Renal and related cancers(127), Prostate Cancer Diagnosis and Treatment(105)

Publications685 total

Prevalence and patterns of sexual dysfunctions among male cancer survivors: real-world evidence from a tertiary andrology centre
International Journal of Impotence Research·2026
Re: Alessandro Parente, Kevin Verhoeff, Yanbo Wang, et al. Robotic and Laparoscopic Adrenalectomy for Pheochromocytoma: An International Multicenter Study: Considerations for Further Research. Eur Urol Focus 2025;11:118–25
European Urology Focus·2025
Intra- and inter-tumoural heterogeneity in von Hippel–Lindau disease-related renal cancer: a multimodal data study protocol
European Radiology Experimental·2025Open Access
Genetic Testing and Counselling for Hereditary Renal Carcinoma: What Do Clinicians Need to Know?
European Urology Open Science·2025· 2 citedOpen Access
Impact of patient characteristics and comorbidities on the risk of postoperative acute kidney injury: a comparative analysis of on clamp vs. off-clamp techniques
World Journal of Urology·2025
Acute kidney injury (AKI) and end stage kidney disease (ESKD) in CKD patients undergoing partial or radical nephrectomy for renal cancer: are we ready to unravel the uncertainty and create new hope?
World Journal of Urology·2025
#1447 Pre-operative CKD stages IIIb–IV in renal cancer surgery: are AKI and ESRD inevitable? Insights from real-life experience
Nephrology Dialysis Transplantation·2025Open Access
#2769 Impact of body mass index (BMI) on renal function decline in high-risk renal cell carcinoma: implications for first-line systemic therapy eligibility
Nephrology Dialysis Transplantation·2025Open Access
Patient-Reported Outcome Measures in Individuals With Hereditary or Sporadic Kidney Cancer: A Comparative Study of Depression and Sexual Function
JCO oncology advances.·2025Open Access
#1446 Beyond the scalpel: how postoperative AKI and comorbidities shape CKD progression after partial nephrectomy
Nephrology Dialysis Transplantation·2025
MRI in combination with Technetium‐99m‐sestamibi single‐photon emission CT/CT: a novel diagnostic algorithm to maximise the characterisation of small renal masses
British Journal of Urology·2025
Robot-assisted radical nephroureterectomy for locally advanced upper tract urothelial carcinoma: a multicenter study by the Junior ERUS/YAU Working Group on Robot-assisted Surgery
European Journal of Surgical Oncology·2025· 2 cited
Current training landscape for novice robotic surgeons: an international investigative survey by the Junior-ERUS/Young academic urologists (YAU) robotics in urology working group
World Journal of Urology·2025Open Access
Epidemiology of Renal Cancer: Incidence, Mortality, Survival, Genetic Predisposition, and Risk Factors
European Urology·2025· 22 cited
Acute Kidney Injury (AKI) and End Stage Kidney Disease (ESKD) in CKD Patients Undergoing Partial or Radical Nephrectomy for Renal Cancer: Are We Ready to Unravel the Uncertainty and Create New Hope?
2025Open Access
Oncological Outcomes After Robotic Salvage Radical Prostatectomy in Patients Primarily Treated With Focal Versus Radiation Therapy: A Junior ERUS/YAU Collaborative Study
The Prostate·2025· 1 citedOpen Access
The OpeRa trial: the active role of the patient in the clinical decision-making process and surgical planning
Annals of Oncology·2025· 1 cited
Implementing Standardised Training and Education: The Vision of the European Association of Urology Led by the European School of Urology
European Urology Open Science·2025Open Access
Abstract A053: A pre-operative Artificial Intelligence-based model to estimate the risk of cancer specific mortality in patients with non-metastatic kidney cancer
Clinical Cancer Research·2025
Real-world challenges and considerations in treating von Hippel-Lindau disease with HIF-2α inhibitors
The Lancet Oncology·2025· 1 cited
page 1 of 35Next →

Frequent Co-authors

Francesco Montorsi(34), Umberto Capitanio(22), Giorgio Guazzoni(20), Nicolò Maria Buffi(16), Massimo Lazzeri(16), Giovanni Lughezzani(14), Nicola Fossati(14), Andrea Minervini(13), Alexandre Mottrie(12), Giuliana Lista(10), Paolo Dell’Oglio(9), Andrea Mari(9), Cristian Fiori(9), Marco Carini(8), Francesco Porpiglia(8), Andrea Cestari(7), Riccardo Autorino(7), Giuseppe Simone(7), F. Porpiglia(7), Alessandro Antonelli(7)